Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
2.520
+0.060 (2.44%)
At close: Jul 21, 2026, 4:00 PM EDT
2.520
0.00 (0.00%)
After-hours: Jul 21, 2026, 4:10 PM EDT
Indaptus Therapeutics Market Cap
Indaptus Therapeutics has a market cap or net worth of $285.37 million as of July 21, 2026. Its market cap has increased by 4,195.92% in one year.
Market Cap
285.37M
Enterprise Value
283.87M
1-Year Change
4,195.92%
Ranking
Category
Stock Price
$2.52
ChartMarket Cap Chart
Since August 4, 2021, Indaptus Therapeutics's market cap has increased from $47.95M to $285.37M, an increase of 495.13%. That is a compound annual growth rate of 43.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 285.37M | 5,500.02% |
| Dec 31, 2025 | 5.10M | -49.63% |
| Dec 31, 2024 | 10.12M | -31.58% |
| Dec 29, 2023 | 14.79M | 21.38% |
| Dec 30, 2022 | 12.18M | -73.92% |
| Dec 31, 2021 | 46.70M | -2.60% |
| Aug 4, 2021 | 47.95M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Turn Therapeutics | 299.37M |
| Eledon Pharmaceuticals | 298.39M |
| Bicycle Therapeutics | 290.41M |
| Immuneering | 277.55M |
| MacroGenics | 274.59M |
| Lineage Cell Therapeutics | 274.23M |
| Niagen Bioscience | 268.96M |
| SAB Biotherapeutics | 268.39M |